MedPeer,Inc.
TSE:6095.T
565 (JPY) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) JPY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 14,540.835 | 8,452.113 | 7,435.418 | 5,311.071 | 3,045.538 | 2,199.164 | 1,559.024 | 973.648 | 1,039.896 | 958.32 | 574.739 |
| Cost of Revenue
| 7,674.181 | 3,418.336 | 2,580.777 | 1,804.858 | 928.356 | 567.617 | 382.506 | 221.301 | 149.692 | 108.176 | 79.853 |
| Gross Profit
| 6,866.654 | 5,033.777 | 4,854.641 | 3,506.213 | 2,117.182 | 1,631.547 | 1,176.518 | 752.347 | 890.204 | 850.144 | 494.886 |
| Gross Profit Ratio
| 0.472 | 0.596 | 0.653 | 0.66 | 0.695 | 0.742 | 0.755 | 0.773 | 0.856 | 0.887 | 0.861 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 291 | 239 | 220 | 188 | 76 | 58 | 72 | 68 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 664 | 686 | 543 | 337 | 239 | 207 | 163 | 104 | 0 | 0 | 0 |
| SG&A
| 5,422.501 | 3,890.999 | 2,986.904 | 2,331.881 | 1,511.327 | 1,217.641 | 1,019.028 | 670.566 | 0 | 0 | 0 |
| Other Expenses
| -0.168 | 3,970.06 | 3,070.733 | 2,401.297 | 1,558.75 | -27.021 | 2.859 | 1.066 | 0.157 | -12.141 | -0.286 |
| Operating Expenses
| 5,746.657 | 3,970.06 | 3,070.733 | 2,401.297 | 1,558.75 | 1,263.691 | 1,094.182 | 694.604 | 753.735 | 585.353 | 405.66 |
| Operating Income
| 1,119.997 | 1,063.716 | 1,783.907 | 1,104.914 | 558.431 | 367.855 | 82.336 | 57.742 | 136.468 | 264.79 | 89.226 |
| Operating Income Ratio
| 0.077 | 0.126 | 0.24 | 0.208 | 0.183 | 0.167 | 0.053 | 0.059 | 0.131 | 0.276 | 0.155 |
| Total Other Income Expenses Net
| -73.391 | 50.047 | 28.105 | 25.753 | -1.037 | -18.881 | -369.663 | -6.487 | -16.787 | -19.627 | -2.505 |
| Income Before Tax
| 1,046.606 | 1,113.763 | 1,812.012 | 1,130.667 | 557.394 | 348.975 | -287.327 | 51.256 | 119.682 | 245.164 | 86.721 |
| Income Before Tax Ratio
| 0.072 | 0.132 | 0.244 | 0.213 | 0.183 | 0.159 | -0.184 | 0.053 | 0.115 | 0.256 | 0.151 |
| Income Tax Expense
| 408.226 | 299.036 | 479.776 | 327.96 | 129.27 | 137.969 | 75.943 | 27.645 | 49.285 | 94.559 | -26.895 |
| Net Income
| 617.678 | 812.388 | 1,293.475 | 725.97 | 394.85 | 206.332 | -363.27 | 23.611 | 70.397 | 150.604 | 113.616 |
| Net Income Ratio
| 0.042 | 0.096 | 0.174 | 0.137 | 0.13 | 0.094 | -0.233 | 0.024 | 0.068 | 0.157 | 0.198 |
| EPS
| 28.33 | 37.62 | 60.07 | 35.03 | 21.04 | 11.46 | -20.9 | 1.38 | 4.18 | 9.91 | 7.75 |
| EPS Diluted
| 27.99 | 35.78 | 56.25 | 32.67 | 19.83 | 11.26 | -20.9 | 1.33 | 3.93 | 9.49 | 7.75 |
| EBITDA
| 1,989.027 | 1,300.588 | 1,991.85 | 1,272.975 | 636.115 | 416.072 | 173.379 | 104.056 | 170.241 | 249.479 | 92.223 |
| EBITDA Ratio
| 0.137 | 0.154 | 0.268 | 0.24 | 0.209 | 0.189 | 0.111 | 0.107 | 0.164 | 0.26 | 0.16 |